APA (7th ed.) Citation

FA, B., S, N., GR, S., JS, K., & PR, L. (2018). Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers in immunology, 9, 1621. https://doi.org/10.3389/fimmu.2018.01621

Chicago Style (17th ed.) Citation

FA, Bidmos, Nadel S, Screaton GR, Kroll JS, and Langford PR. "Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0." Frontiers in Immunology 9 (2018): 1621. https://doi.org/10.3389/fimmu.2018.01621.

MLA (9th ed.) Citation

FA, Bidmos, et al. "Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0." Frontiers in Immunology, vol. 9, 2018, p. 1621, https://doi.org/10.3389/fimmu.2018.01621.